Acadia Healthcare Company, INC DEF 14A proxy statements
Proxy statements, covering the matters put to shareholders at the annual meeting — board elections, auditor ratification and executive pay.
NASDAQ
Acadia Healthcare Company, Inc. reports significant financial underperformance in 2025, marked by a substantial net loss and missed executive compensation targets, while seeking shareholder approval for key governance matters and an expanded incentive plan.
NASDAQ
Acadia Healthcare Company, Inc. has filed a definitive proxy statement with the Securities and Exchange Commission.
NASDAQ
DEF: Acadia Healthcare Seeks Stockholder Approval for Incentive Plan Amendment at 2025 Annual Meeting
Acadia Healthcare is asking stockholders to approve an amendment to its incentive compensation plan to increase the number of shares available for issuance at the 2025 annual meeting.
NASDAQ
Acadia Healthcare Company, Inc. has filed a definitive proxy statement with the SEC.
NASDAQ
Acadia Healthcare's upcoming annual meeting will address the declassification of the Board of Directors and executive compensation, among other key proposals.